LEVOBUNOLOL HYDROCHLORIDE solution/ drops USA - engelsk - NLM (National Library of Medicine)

levobunolol hydrochloride solution/ drops

bausch & lomb incorporated - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 5 mg in 1 ml - levobunolol hydrochloride ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. levobunolol hydrochloride ophthalmic solution is contraindicated in those individuals with bronchial asthma, or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.

LEVOBUNOLOL HYDROCHLORIDE solution/ drops USA - engelsk - NLM (National Library of Medicine)

levobunolol hydrochloride solution/ drops

pacific pharma, inc. - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 2.5 mg in 1 ml - levobunolol hcl ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. levobunolol hcl ophthalmic solution is contraindicated in those individuals with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.

Levobunolol Hydrochloride Eye Drops 0.5% New Zealand - engelsk - Medsafe (Medicines Safety Authority)

levobunolol hydrochloride eye drops 0.5%

alcon laboratories australia pty ltd (nz) - levobunolol hydrochloride 0.5%{relative} - eye drops, solution - 0.5% w/v - active: levobunolol hydrochloride 0.5%{relative} excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate hydrochloric acid monobasic potassium phosphate polyvinyl alcohol purified water sodium chloride sodium hydroxide sodium metabisulfite

LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION LIQUID Canada - engelsk - Health Canada

levobunolol hydrochloride ophthalmic solution liquid

bausch & lomb pharmaceuticals inc. - levobunolol hydrochloride - liquid - 0.50% - levobunolol hydrochloride 0.50% - beta-adrenergic agents

LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION LIQUID Canada - engelsk - Health Canada

levobunolol hydrochloride ophthalmic solution liquid

alcon canada inc - levobunolol hydrochloride - liquid - 0.50% - levobunolol hydrochloride 0.50% - beta-adrenergic agents

Betagan New Zealand - engelsk - Medsafe (Medicines Safety Authority)

betagan

abbvie limited - levobunolol hydrochloride 0.5%{relative};  ;  ;   - eye drops, solution - 0.5 % - active: levobunolol hydrochloride 0.5%{relative}       excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate disodium edetate hydrochloric acid monobasic potassium phosphate polyvinyl alcohol purified water sodium chloride sodium hydroxide sodium metabisulfite

BETAGAN- levobunolol hydrochloride solution/ drops USA - engelsk - NLM (National Library of Medicine)

betagan- levobunolol hydrochloride solution/ drops

allergan, inc. - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 5 mg in 1 ml - betagan ® ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. betagan ® ophthalmic solution is contraindicated in those individuals with bronchial asthma, or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.

RATIO-LEVOBUNOLOL SOLUTION Canada - engelsk - Health Canada

ratio-levobunolol solution

teva canada limited - levobunolol hydrochloride - solution - 0.25% - levobunolol hydrochloride 0.25% - beta-adrenergic agents

RATIO-LEVOBUNOLOL SOLUTION Canada - engelsk - Health Canada

ratio-levobunolol solution

teva canada limited - levobunolol hydrochloride - solution - 0.5% - levobunolol hydrochloride 0.5% - beta-adrenergic agents

Allergan Levobunolol New Zealand - engelsk - Medsafe (Medicines Safety Authority)

allergan levobunolol

allergan new zealand ltd - levobunolol hydrochloride 0.25%{relative};   - eye drops, solution - 0.25 % - active: levobunolol hydrochloride 0.25%{relative}   excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate disodium edetate dihydrate monobasic potassium phosphate polyvinyl alcohol purified water sodium chloride sodium hydroxide sodium metabisulfite